Immune-Related Adverse Events: Pneumonitis.

Zhong, Linda; Altan, Mehmet; Shannon, Vickie R; Sheshadri, Ajay

Zhong, Linda; Altan, Mehmet; Shannon, Vickie R; Sheshadri, Ajay.

Afiliação

Zhong L; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shannon VR; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sheshadri A; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. asheshadri@mdanderson.org.

Adv Exp Med Biol ; 1244: 255-269, 2020.

Article em En | MEDLINE | ID: mdl-32301020

Assuntos

Imunoterapia/efeitos adversos; Neoplasias/terapia; Pneumonia/induzido quimicamente; Pneumonia/imunologia; Humanos; Incidência; Neoplasias/imunologia; Pneumonia/epidemiologia; Pneumonia/terapia

Palavras-chave

Checkpoint inhibitors; Diffuse alveolar damage; Hypersensitivity pneumonitis; Immune-related adverse event; Nonspecific interstitial pneumonia; Organizing pneumonia; Pneumonitis; Thoracic imaging

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Imunoterapia / Neoplasias Tipo de estudo: Guideline / Incidence_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Adv Exp Med Biol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google